COPD
Conditions
Brief summary
There is lack of quality control and evaluation indexes for standard COPD management in hospitals in China, leading to nonstandard in COPD management and discrepancy in therapeutic efficiency. This study focuses on establishing quality control and evaluation indexes for standard COPD management in hospitals in China, and evaluating the therapeutic efficiency after standard COPD management. This part is a prospective cohort which lasts 2 years. After standard COPD management according to GOLD 2017 by doctors in hospitals in China, patients will be followed up for their outcome after 1 year. Several indexes will be selected to evaluate the quality control of standard COPD management and its efficiency. The controls are from hospital-based subjects with a retrospective cohort study.
Interventions
OTHERGOLD 2017
Standard COPD management according to GOLD 2017, and control the quality of management in one-year follow-up.
Sponsors
Affiliated hospital of Guilin medical university,China
University hospital of Hubei university for nationalities,China
TongjiChibi hospital,China
Central health center in Yongjiahe Town,China
Chinses PLA general hospital
Second Xiangya Hospital of Central South University
the fourth affiliated hospital, Zhejiang university school of medcine
First Hospital of China Medical University
Peking University Third Hospital
Huashan Hospital
First Affiliated Hospital Xi'an Jiaotong University
Shanghai Zhongshan Hospital
Shanghai Ninth People's Hospital Affiliated to Shanghai Jiao Tong University
Yiwu Central Hospital
Shanghai Xuhui Central Hospital
Sijing hospital of Songjiang District in Shanghai
Youxian People's Hospital
Tong Ren hospital Shanghai Jiao Tong university school of medicine
Zhejiang Putuo Hospital
Jing-An District Center Hospital of Shanghai (Huashan Hospital Fudan University Jing-An Branch), Shanghai Medical College, Fudan University
Tongji Hospital
Study design
Observational model
COHORT
Time perspective
OTHER
Eligibility
Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No
Inclusion criteria
* 1.Clinical manifestation of COPD; post bronchodilator FEV1/FVC\<0.70
Exclusion criteria
* 1\. lung cancer. 2. Any history of psychiatric disorders. 3.HIV positive. 4.Breastfeeding, pregnancy or planning to be pregnant. 5.Estimated lifetime less than 1 years due to underlying diseases.
Design outcomes
Primary
| Measure | Time frame | Description |
|---|---|---|
| Change in spirometry | 1 years | Spirometry will be assessed at baseline and through study completion |
Secondary
| Measure | Time frame | Description |
|---|---|---|
| Morbidity of acute exacerbation in 1 years | 1 year | Morbidity of acute exacerbation completion will be assessed at baseline and through study |
Countries
China
Outcome results
None listed